Treatment with the chimeric anti-IL-2Rα basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation

2001-04-05

Transplantation Proceedings , Volume 33 - Issue 1-2 p. 1007- 1008

Additional Metadata
Persistent URL	doi.org/10.1016/S0041-1345(00)02306-X, hdl.handle.net/1765/52484
Journal	Transplantation Proceedings
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Boelaars-van Haperen, M. J. A. M., Baan, C., van Riemsdijk, I., IJzermans, J., & Weimar, W. (2001). Treatment with the chimeric anti-IL-2Rα basiliximab affects both the IL-2 and IL-15 signalling pathways after clinical kidney transplantation. In Transplantation Proceedings (Vol. 33, pp. 1007–1008). doi:10.1016/S0041-1345(00)02306-X

Publication